Global Preventive Asthma Drugs Market Trends, Applications, Analysis, Growth, and Forecast to 2027

MarketResearch.Biz delivers in-depth insights in its upcoming report titled “Global Preventive Asthma Drugs Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global preventive asthma drugs market is expected to register a CAGR of X.X% in terms of value during forecast period, 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global preventive asthma drugs market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report provides insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global preventive asthma drugs market report has been segmented on the basis of type, application, and region.

Asthma is a chronic disease of the air passages of the lungs which inflames and narrows them, causing continuous attacks of breathlessness, bronchospasm and reversible airflow obstruction. Asthma is considered to be one of the most common disease to affect the population worldwide, it is also a life threatening disease which affects normal breathing in patients. Over XX million people worldwide are affected by this chronic condition, while there were about XX reported deaths caused due to asthma in 2015.

Fundamental causes of asthma include air pollution, tobacco smoke, chemical irritants, indoor and outdoor allergens. There is a significant rise in asthma cases, due to rise in air pollution in a high number of urban, as well as, rural areas worldwide. There is a considerable increase in the number of smokers, which induces the symptoms for asthma. Moreover, rise in industrialization has also led to an increase in the number of asthma cases, which will drive the market for preventive asthma medications globally during the forecast period.

Major pharmaceuticals giants are continuously investing in their R&D activities for developing better preventive asthma medications, which is also likely to fuel the global preventive asthma medications market. Furthermore, the ongoing trend in healthcare industry is providing advanced therapies which is further expected to drive growth of target market over the forecast period. One of the major restraining factor for this market is the unknown etiology for this condition. Lack of manufacturing facilities, technologies and high dependence on imports are other key factors hampering the growth of the preventive asthma drugs market in some developing regions.

North America dominates the global market, followed by Europe, mainly due to heightened awareness about the disease and good quality healthcare system. Nonetheless, the Asia Pacific market is expected to witness the highest growth during the forecast period owing to increase in incidence of asthma and adoption of modern lifestyles. In addition, rise in number of contract manufacturing organizations in Asia Pacific drives the preventive asthma drugs market in the region. Regions such as Southeast Asia and Africa have highest mortality rates and high demand for asthma preventive medicines, as some of the countries in these regions have less access to essential medicines.

Segmentation on the basis of types are:

• Immunosuppressants
• Leukotriene antagonists
• Mast cell stabilizers
• Corticosteroids
• Combination of LABA/ ICS

Segmentation on the basis of application model are:

• Children
• Adult

Segmentation on the basis of region are:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• AstraZeneca
• Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Novartis
• Abbott
• Amgen
• AptarGroup
• Biotest
• Boehringer Ingelheim